Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.

The complex biantennary oligosaccharide at Asn297 of IgG is essential for some effector functions. To investigate the effect of carbohydrate structure on Ab function, we have now expressed mouse-human chimeric IgG1 Abs in Chinese hamster ovary (CHO) cells with defined defects in carbohydrate biosynthesis. We had previously shown that IgG1 Abs produced in the cell line Lec 1, which attaches a high-mannose intermediate carbohydrate, were severely deficient in complement activation, showed a slightly reduced affinity for Fc gammaRI, and had a reduced in vivo half-life. We have extended these studies by producing the same dansyl-specific IgG1 in cell lines deficient in attachment of sialic acid (Lec 2) and galactose (Lec 8). IgG1-Lec 1, IgG1-Lec 2, and IgG1-Lec 8 all showed varying reactivity with a mAb specific for an epitope in the amino terminal region of C(H)2, suggesting that the conformations of these proteins were altered by the different carbohydrate structures. Functionally, IgG1-Lec 2 and IgG1-Lec 8 were comparable to wild type with respect to in vivo half-life, affinity for Fc gammaRI, and capacity for complement-mediated hemolysis. While IgG1-Lec 2 was essentially identical to wild type in its capacity to interact with individual components of the classical complement activation pathway, IgG1-Lec 8 demonstrated equivalent maximal binding at lower concentrations and was preferentially bound by mannose-binding protein. Although IgG1-Lec 1 was deficient in activation of the classical pathway, it had a superior capacity to activate the alternative pathway. These studies demonstrate that Abs bearing C(H)2-linked carbohydrate of differing structures have different functional properties.

[1]  S L Morrison,et al.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. , 1989, Journal of immunology.

[2]  S. Morrison,et al.  The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin g , 1994, Cancer.

[3]  J. Baynes,et al.  Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG-antigen complexes. , 1980, The Journal of biological chemistry.

[4]  M. Silberklang,et al.  Structural characterization of the N-glycans of a humanized anti-CD18 murine immunoglobulin G. , 1994, Archives of biochemistry and biophysics.

[5]  T. Rademacher,et al.  Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. , 1994, Human antibodies and hybridomas.

[6]  Shigeru FujiiS,et al.  Structural Heterogeneity of Sugar Chains in Immunoglobulin G , 1990 .

[7]  S L Morrison,et al.  Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1 , 1994, The Journal of experimental medicine.

[8]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[9]  R. Dwek,et al.  Tissue‐specific N‐glycosylation, site‐specific oligosaccharide patterns and lentil lectin recognition of rat Thy‐1. , 1987, The EMBO journal.

[10]  R. Jefferis,et al.  Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. , 1996, Journal of immunology.

[11]  A. Shimizu,et al.  Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. , 1982, Journal of immunology.

[12]  H. Wigzell,et al.  Biological significance of carbohydrate chains on monoclonal antibodies. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Morrison,et al.  Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation , 1993, The Journal of experimental medicine.

[14]  A K Patel,et al.  The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. , 1995, Molecular immunology.

[15]  D R Burton,et al.  Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. , 1985, Molecular immunology.

[16]  Z. Fishelson,et al.  C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium. , 1982, Journal of immunology.

[17]  R. Dwek,et al.  Immunoglobulin G as a glycoprotein. , 1986, Biochemical Society symposium.

[18]  R. Jefferis,et al.  Recognition sites on human IgG for Fcγ receptors: the role of glycosylation , 1995 .

[19]  R. Jefferis,et al.  Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. , 1989, The Biochemical journal.

[20]  R. Jefferis,et al.  Oligosaccharide‐protein interactions in IgG can modulate recognition by Fcγ receptors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  S. Fujii,et al.  Structural heterogeneity of sugar chains in immunoglobulin G. Conformation of immunoglobulin G molecule and substrate specificities of glycosyltransferases. , 1990, The Journal of biological chemistry.

[22]  S. Morrison,et al.  The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region , 1991, The Journal of experimental medicine.

[23]  D. Phillips,et al.  The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. , 1983, Biochemical Society transactions.

[24]  E. Kabat,et al.  Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. , 1991, The EMBO journal.

[25]  P. Stanley Glycosylation mutants of animal cells. , 1984, Annual review of genetics.

[26]  Y. Masuho,et al.  Structural study of the sugar moieties of monoclonal antibodies secreted by human-mouse hybridoma. , 1991, Archives of biochemistry and biophysics.

[27]  D. Isenberg,et al.  Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. , 1992, The Journal of clinical investigation.

[28]  R. Jefferis,et al.  Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst. , 1993, Molecular immunology.

[29]  M. Malaise,et al.  Evidence for a role of accessible galactosyl or mannosyl residues of Fc domain in the in vivo clearance of IgG antibody-coated autologous erythrocytes in the rat. , 1990, Clinical immunology and immunopathology.

[30]  E. Ward,et al.  Catabolism of the Murine IgGl Molecule: Evidence that Both CH2‐CH3 Domain Interfaces are Required for Persistence of IgGl in the Circulation of Mice , 1994 .

[31]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[32]  S. Foundling,et al.  Effect of immunoglobulin variable region structure on C3b and C4b deposition. , 1996, Molecular immunology.

[33]  T Miyamoto,et al.  Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. , 1989, The Journal of rheumatology.

[34]  P. Stanley Glycosylation mutants and the functions of mammalian carbohydrates , 1987 .

[35]  M Goodall,et al.  Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. , 1993, Molecular immunology.

[36]  J. Schweinle,et al.  Distinct and overlapping functions of allelic forms of human mannose binding protein , 1992, Nature genetics.

[37]  T. Bentley,et al.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. , 1992, Immunology letters.

[38]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[39]  Eleftherios T. Papoutsakis,et al.  Culture pH Affects Expression Rates and Glycosylation of Recombinant Mouse Placental Lactogen Proteins by Chinese Hamster Ovary (CHO) Cells , 1993, Bio/Technology.